• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Biosens Bioelectron . CRISPR-based detection of SARS-CoV-2: A review from sample to result

tetano

Editor, Senior Moderator
Biosens Bioelectron


. 2021 Jan 21;178:113012.
doi: 10.1016/j.bios.2021.113012. Online ahead of print.
CRISPR-based detection of SARS-CoV-2: A review from sample to result


Reza Nouri[SUP] 1 [/SUP], Zifan Tang[SUP] 1 [/SUP], Ming Dong[SUP] 1 [/SUP], Tianyi Liu[SUP] 1 [/SUP], Aneesh Kshirsagar[SUP] 1 [/SUP], Weihua Guan[SUP] 2 [/SUP]



Affiliations

Abstract

The current pandemic of the 2019 novel coronavirus (COVID-19) caused by SARS-CoV-2 (severe acute respiratory syndrome coronavirus-2) has raised significant public health concern. Rapid, affordable, and accurate diagnostics of SARS-CoV-2 is essential for early treatment and control of the disease spread. In the past few years, CRISPR technology has shown great potential for highly sensitive and specific molecular diagnostics. Amid the ongoing COVID-19 pandemic, there is an increasing interest in implementing CRISPR-based diagnostic principles to develop fast and precise methods for detecting SARS-CoV-2. In this work, we reviewed and summarized these CRISPR-based diagnostic systems as well as their characteristics and challenges. We also provided future perspectives of CRISPR-based sensing towards point-of-care molecular diagnosis applications.

Keywords: COVID-19; CRISPR; Cas12; Cas13; Point-of-care diagnosis; SARS-CoV-2.
 
Back
Top Bottom